These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30646614)

  • 1. Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips.
    Kulasinghe A; Zhou J; Kenny L; Papautsky I; Punyadeera C
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30646614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Collective Route to Head and Neck Cancer Metastasis.
    Kulasinghe A; Schmidt H; Perry C; Whitfield B; Kenny L; Nelson C; Warkiani ME; Punyadeera C
    Sci Rep; 2018 Jan; 8(1):746. PubMed ID: 29335441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of label-free technologies in head and neck cancer circulating tumour cells.
    Kulasinghe A; Kenny L; Perry C; Thiery JP; Jovanovic L; Vela I; Nelson C; Punyadeera C
    Oncotarget; 2016 Nov; 7(44):71223-71234. PubMed ID: 27655722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery.
    Payne K; Brooks JM; Taylor GS; Batis N; Noyvert B; Pan Y; Nankivell P; Mehanna H
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of circulating tumour cells to predict response to treatment in head and neck cancer.
    Zhang X; Ekanayake Weeramange C; Hughes BGM; Vasani S; Liu ZY; Warkiani ME; Hartel G; Ladwa R; Thiery JP; Kenny L; Punyadeera C
    Cell Oncol (Dordr); 2022 Aug; 45(4):543-555. PubMed ID: 35737211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
    Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
    Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
    Cells; 2021 May; 10(5):. PubMed ID: 34068719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrichment of circulating head and neck tumour cells using spiral microfluidic technology.
    Kulasinghe A; Tran TH; Blick T; O'Byrne K; Thompson EW; Warkiani ME; Nelson C; Kenny L; Punyadeera C
    Sci Rep; 2017 Feb; 7():42517. PubMed ID: 28198401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of rare circulating tumour cells in cancer patients by microchip technology.
    Nagrath S; Sequist LV; Maheswaran S; Bell DW; Irimia D; Ulkus L; Smith MR; Kwak EL; Digumarthy S; Muzikansky A; Ryan P; Balis UJ; Tompkins RG; Haber DA; Toner M
    Nature; 2007 Dec; 450(7173):1235-9. PubMed ID: 18097410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.
    Jie XX; Zhang M; Du M; Cai QQ; Cong Q; Xu CJ; Zhang XY
    Transl Cancer Res; 2022 Aug; 11(8):2636-2646. PubMed ID: 36093536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma.
    Guan Y; Xu F; Tian J; Gao K; Wan Z; Wang Y; Gao M; Wang Z; Chong T
    BMC Cancer; 2021 Jul; 21(1):826. PubMed ID: 34271857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models.
    Hassan S; Blick T; Thompson EW; Williams ED
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34206049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells.
    Lin M; Chen JF; Lu YT; Zhang Y; Song J; Hou S; Ke Z; Tseng HR
    Acc Chem Res; 2014 Oct; 47(10):2941-50. PubMed ID: 25111636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of two methods for the detection of circulating tumour cells in patients with oral cavity cancer.
    Curtin J; Wong G; Wang W; Thomson P; Lam AK; Choi SW
    J Oral Pathol Med; 2022 Mar; 51(3):249-255. PubMed ID: 34586677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
    Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients.
    Zeinali M; Lee M; Nadhan A; Mathur A; Hedman C; Lin E; Harouaka R; Wicha MS; Zhao L; Palanisamy N; Hafner M; Reddy R; Kalemkerian GP; Schneider BJ; Hassan KA; Ramnath N; Nagrath S
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of circulating tumor cells and microemboli to predict diagnosis and prognosis in diffuse glioma.
    Qi Y; Xu Y; Yan T; Xiong W; Zhu X; Sun Q; Deng G; Yuan F; Ye L; Hu P; Liu B; Zhang S; Deng S; He Y; Wu G; Ye Q; Chen Q
    J Neurosurg; 2024 Sep; 141(3):673-683. PubMed ID: 38608304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
    Wang C; Mu Z; Chervoneva I; Austin L; Ye Z; Rossi G; Palazzo JP; Sun C; Abu-Khalaf M; Myers RE; Zhu Z; Ba Y; Li B; Hou L; Cristofanilli M; Yang H
    Breast Cancer Res Treat; 2017 Jan; 161(1):83-94. PubMed ID: 27771841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microfluidic device for label-free, physical capture of circulating tumor cell clusters.
    Sarioglu AF; Aceto N; Kojic N; Donaldson MC; Zeinali M; Hamza B; Engstrom A; Zhu H; Sundaresan TK; Miyamoto DT; Luo X; Bardia A; Wittner BS; Ramaswamy S; Shioda T; Ting DT; Stott SL; Kapur R; Maheswaran S; Haber DA; Toner M
    Nat Methods; 2015 Jul; 12(7):685-91. PubMed ID: 25984697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.